Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model.
about
Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6Reactive Oxygen Species in Mesenchymal Stem Cell Aging: Implication to Lung DiseasesHuman mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trialsUsing Cell-Based Strategies to Break the Link between Bronchopulmonary Dysplasia and the Development of Chronic Lung Disease in Later LifeAdipose-derived stromal cell therapy affects lung inflammation and tracheal responsiveness in guinea pig model of COPDHuman embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney diseaseA prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.Stem cells and cell therapies in lung biology and diseases: conference report.Tracking intravenous adipose-derived mesenchymal stem cells in a model of elastase-induced emphysemaThe clinical use of regenerative therapy in COPDLung Regeneration Therapy for Chronic Obstructive Pulmonary Disease.In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viabilityMesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1.Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lungInteraction between mesenchymal stem cells and endothelial cells restores endothelial permeability via paracrine hepatocyte growth factor in vitro.N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction.Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosisThe Therapeutic Effects of Optimal Dose of Mesenchymal Stem Cells in a Murine Model of an Elastase Induced-Emphysema.Stem cells and regenerative medicine in lung biology and diseases.Preclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis.Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol alleviates elastase-induced emphysema in a mouse modelNovel therapy for idiopathic pulmonary arterial hypertension: Can hepatocyte growth factor be beneficial?A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.Regenerative pulmonary medicine: potential and promise, pitfalls and challenges.TNF-α and IL-1β-activated human mesenchymal stromal cells increase airway epithelial wound healing in vitro via activation of the epidermal growth factor receptorStem cell recruitment after injury: lessons for regenerative medicine.Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years.Therapeutic effects of adipose-derived stem cells pretreated with pioglitazone in an emphysema mouse model.Gene Profiles in a Smoke-Induced COPD Mouse Lung Model Following Treatment with Mesenchymal Stem Cells.Human mesenchymal stromal cells exert HGF dependent cytoprotective effects in a human relevant pre-clinical model of COPD.The effect of adipose derived stromal cells on oxidative stress level, lung emphysema and white blood cells of guinea pigs model of chronic obstructive pulmonary disease.Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway.Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.Exosomes derived from mesenchymal stem cells.Growth factors, stem cells and bronchopulmonary dysplasia.Experimental basis and new insights for cell therapy in Chronic Obstructive Pulmonary Disease.The potential of cell-based therapy in lung diseases.STAT3 signaling in pulmonary arterial hypertension.Mesenchymal stem cells for therapeutic applications in pulmonary medicine.Growth factors enhance liver regeneration in acute-on-chronic liver failure.
P2860
Q24302245-6D44C341-9E50-4A26-8FC9-34F98741C569Q26798204-266B5673-E3C7-43EB-A336-78D505B88DFEQ28071916-1DB8A54B-E9FB-464F-B0A4-598670E2201CQ28393759-5139E26F-D081-45B5-B3CE-E990DF392ACFQ28543924-7D3C432A-AD10-4708-8800-52521C87987CQ28728256-C04C7C18-1004-454C-965B-0EEBD0FA6888Q30541785-327EA8AC-6C34-44C0-B4FB-A308DC9CE743Q33811247-A3704C82-5E07-45A9-A6D2-C5FD097FADB3Q34316601-59333E23-7EA6-4433-915D-38DB416C07B5Q34456011-9A9C5E22-F2E8-475C-8F51-54ABDC530641Q34549985-08CE40E8-755E-4BDC-9413-7CE24F60B5EFQ35078827-DA0F395D-0E07-4CAD-BA4E-0F540885D0C5Q35153085-D0442784-21F2-46C8-B993-BE2BAFB5182FQ35237421-B49FACA6-32F4-4E41-B794-2C0082A47817Q35605408-3AA9EAAC-E336-4C42-9FE0-3B86290B5544Q35665230-305AA885-2F6E-4A5D-B4ED-8870DFCBF25CQ35805322-0E413A3C-03EC-4102-B94E-0442ABA5CC98Q35843820-7C53C2AB-939F-417F-9611-48B9E447E5B6Q36014064-21DF49A7-B7E6-42EF-A1E5-1A7E507CD11AQ36046310-5AFABE17-E6FB-4BDB-B44E-3D17EB3DEE28Q36127872-7397DCBC-A3E0-4EBD-92E0-C543AC4A9145Q36163732-C11C7C91-4412-430A-A4C5-AF0379078DF7Q36411255-AA5060E1-DDB0-4AAC-B7DB-7029A1CBDA71Q36441932-B25EA896-FF6B-4D1C-9B7A-11544D8D2649Q36454721-41EAFD77-3018-463E-ACE2-216E8D551110Q36599286-A0A47866-818C-42C5-A11E-FDF69022036BQ37320726-618D12E9-6312-4AB4-B143-DB200D1C48B6Q37399408-83131563-7994-4511-B429-F522976F48C2Q37408240-F974B01F-FB79-4AA8-A024-6D55D739510FQ37475850-E356475A-291A-455F-9CE9-A2E3DEA9A496Q37580621-9369293C-FA0F-437B-A7D2-65C7B0076FB2Q37624464-0712F22D-12E2-4947-A487-2E16A3677947Q37651549-82499128-370E-429B-B021-9CCC5F0A3281Q37684037-314D0FBE-3F84-47C4-AAB7-A6F6AF911BBEQ37893904-0B6E1DBA-5A6A-4CEF-898D-33D151DF7BB7Q38051255-9A9D5D71-CAED-4082-8F0D-47D580259201Q38132249-0E019DD6-D1D1-4547-BBFB-6A5219D025EFQ38140894-96D52CAC-0F09-40E0-9B8D-F614DDE82B8EQ38524367-67227E86-804D-431C-864A-1F1859F72394Q38552119-097AD3B1-6A37-4E2B-AA92-0930E9892C72
P2860
Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Paracrine factors of multipote ...... stase-induced emphysema model.
@en
Paracrine factors of multipote ...... stase-induced emphysema model.
@nl
type
label
Paracrine factors of multipote ...... stase-induced emphysema model.
@en
Paracrine factors of multipote ...... stase-induced emphysema model.
@nl
prefLabel
Paracrine factors of multipote ...... stase-induced emphysema model.
@en
Paracrine factors of multipote ...... stase-induced emphysema model.
@nl
P2093
P2860
P356
P1433
P1476
Paracrine factors of multipote ...... stase-induced emphysema model.
@en
P2093
Ahmed M Katsha
Masahiko Kanehira
Ruowen Sun
Shinya Ohkouchi
Toshihiro Nukiwa
Yasuo Saijo
P2860
P304
P356
10.1038/MT.2010.192
P577
2010-09-14T00:00:00Z